Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances and prospects of biomarkers for immune checkpoint inhibitors
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101621-101621
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
Bicheng Ye, Jun Fan, Lei Xue, et al.
iMeta (2025)
Open Access | Times Cited: 9
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 10
InterobServer AgreeMent in Pd‐l1 evaLuatIoN on cytoloGical samples—SAMPLING project: A multi‐institutional, international study
Gennaro Acanfora, Antonino Iaccarino, Bruna Cerbelli, et al.
Cancer Cytopathology (2025) Vol. 133, Iss. 3
Open Access | Times Cited: 1
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 6
Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
Bicheng Ye, Aimin Jiang, Liang Feng, et al.
BioFactors (2024)
Closed Access | Times Cited: 5
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
Huayi Li, Yancheng Xu, Xiaofei Jiao, et al.
Med (2025), pp. 100573-100573
Closed Access
Identification and validation VAT1 in gastric cancer through bioinformatics and experimental analysis
Yongli Hu, Yan Du, Zhisheng Qiu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114047-114047
Closed Access
Glycoscience in Advancing PD-1/PD-L1-Axis-Targeted Tumor Immunotherapy
Qianqian Sun, Senlian Hong
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1238-1238
Open Access
The critical role of immune response in lung cancer and its treatment progress
Ying Zhang
New discovery. (2025), pp. 1-12
Closed Access
ZFP64 predicts the prognosis and response to immune checkpoint inhibition in lung adenocarcinoma
Jin-Zhou Fang, Yongqin Liu, Xuan Wu, et al.
Asian Journal of Surgery (2025)
Open Access
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit
Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Unravelling Cancer Immunity: Coagulation.Sig and BIRC2 as Predictive Immunotherapeutic Architects
Ziang Yao, Jun Fan, Yucheng Bai, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
Lack of consistent effect of dietary fiber on immune checkpoint blockade efficacy across diverse murine tumor models
Asael Roichman, Gabriela Reyes‐Castellanos, Ziqing Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Anti-tumor effectiveness of a novel bispecific antibody that blocks both PD-L1 and LAG-3
Chenxing Zhang, Jiaxin Liu, Mingzhe Sun, et al.
Molecular Immunology (2025) Vol. 182, pp. 30-40
Open Access
CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer Immunotherapy
Rosaely Casalegno‐Garduño, Alf Spitschak, Tim Pannek, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 930-930
Open Access
New horizons at the interface of artificial intelligence and translational cancer research
Josephine Yates, Eliezer M. Van Allen
Cancer Cell (2025) Vol. 43, Iss. 4, pp. 708-727
Closed Access
The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
Liuyue Kan, Yingyan Yu, Yan‐Jiang Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice
Yuki Maruyama, Masahiro Hosonuma, Hitoshi Toyoda, et al.
European Journal of Pharmacology (2025), pp. 177704-177704
Closed Access
Deciphering breast cancer prognosis: a novel machine learning-driven model for vascular mimicry signature prediction
Xue Li, Xukui Li, Bin Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Overcoming Resistance Mechanisms to Melanoma Immunotherapy
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 2
Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency
Fabrizio Nelli, Enzo Maria Ruggeri, Marta Schirripa, et al.
Current Oncology (2024) Vol. 31, Iss. 12, pp. 7647-7662
Open Access | Times Cited: 1
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Zijie Guo, Ziyu Zhu, Xixi Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Integrated analysis and experiments uncover the function of disulfidptosis in predicting immunotherapy effectiveness and delineating immune landscapes in uterine corpus endometrial carcinoma
Lei Han, Yilin Li, Yanjie Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Some Glycoproteins Expressed on the Surface of Immune Cells and Cytokine Plasma Levels Can Be Used as Potential Biomarkers in Patients with Colorectal Cancer
Tsvetelina Batsalova, Denitsa Uzunova, Gergana Chavdarova, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1314-1314
Open Access
Page 1 - Next Page

Scroll to top